Study to determine the Effect of Amritadi Kwatha and Guda-Haritaki in the management of Vatarakta w.s.r. to Hyperuricemia
Phase 1
- Conditions
- Health Condition 1: M104- Other secondary gout
- Registration Number
- CTRI/2021/05/033377
- Lead Sponsor
- Principal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patient having S.uric acid level > 7mg/dl in males and > 6mg/dl in females with or without any associated features of joint inflammation
2. Willing to participate and able to provide signed informed consent.
Exclusion Criteria
Patient not willing for trial.
Below the age of 20 and above 60 yrs.
Having other problems like osteoarthritis, tubercular arthritis, rheumatoid arthritis.
Suffering from chronic renal, respiratory, cardiac, hepatic and malignant disorder.
Female patients who are pregnant and lactating.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fulfillment of objective and subjective criteriaTimepoint: 6 weeks
- Secondary Outcome Measures
Name Time Method Change in serum uric acid level from base line <br/ ><br>Change in clinical featuresTimepoint: 6 weeks